Cargando…
Essential Medicines at the National Level: The Global Asthma Network’s Essential Asthma Medicines Survey 2014
Patients with asthma need uninterrupted supplies of affordable, quality-assured essential medicines. However, access in many low- and middle-income countries (LMICs) is limited. The World Health Organization (WHO) Non-Communicable Disease (NCD) Global Action Plan 2013–2020 sets an 80% target for ess...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406388/ https://www.ncbi.nlm.nih.gov/pubmed/30791442 http://dx.doi.org/10.3390/ijerph16040605 |
_version_ | 1783401290863214592 |
---|---|
author | Bissell, Karen Ellwood, Philippa Ellwood, Eamon Chiang, Chen-Yuan Marks, Guy B. El Sony, Asma Asher, Innes Billo, Nils Perrin, Christophe |
author_facet | Bissell, Karen Ellwood, Philippa Ellwood, Eamon Chiang, Chen-Yuan Marks, Guy B. El Sony, Asma Asher, Innes Billo, Nils Perrin, Christophe |
author_sort | Bissell, Karen |
collection | PubMed |
description | Patients with asthma need uninterrupted supplies of affordable, quality-assured essential medicines. However, access in many low- and middle-income countries (LMICs) is limited. The World Health Organization (WHO) Non-Communicable Disease (NCD) Global Action Plan 2013–2020 sets an 80% target for essential NCD medicines’ availability. Poor access is partly due to medicines not being included on the national Essential Medicines Lists (EML) and/or National Reimbursement Lists (NRL) which guide the provision of free/subsidised medicines. We aimed to determine how many countries have essential asthma medicines on their EML and NRL, which essential asthma medicines, and whether surveys might monitor progress. A cross-sectional survey in 2013–2015 of Global Asthma Network principal investigators generated 111/120 (93%) responses—41 high-income countries and territories (HICs); 70 LMICs. Patients in HICs with NRL are best served (91% HICs included ICS (inhaled corticosteroids) and salbutamol). Patients in the 24 (34%) LMICs with no NRL and the 14 (30%) LMICs with an NRL, however no ICS are likely to have very poor access to affordable, quality-assured ICS. Many LMICs do not have essential asthma medicines on their EML or NRL. Technical guidance and advocacy for policy change is required. Improving access to these medicines will improve the health system’s capacity to address NCDs. |
format | Online Article Text |
id | pubmed-6406388 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-64063882019-03-21 Essential Medicines at the National Level: The Global Asthma Network’s Essential Asthma Medicines Survey 2014 Bissell, Karen Ellwood, Philippa Ellwood, Eamon Chiang, Chen-Yuan Marks, Guy B. El Sony, Asma Asher, Innes Billo, Nils Perrin, Christophe Int J Environ Res Public Health Article Patients with asthma need uninterrupted supplies of affordable, quality-assured essential medicines. However, access in many low- and middle-income countries (LMICs) is limited. The World Health Organization (WHO) Non-Communicable Disease (NCD) Global Action Plan 2013–2020 sets an 80% target for essential NCD medicines’ availability. Poor access is partly due to medicines not being included on the national Essential Medicines Lists (EML) and/or National Reimbursement Lists (NRL) which guide the provision of free/subsidised medicines. We aimed to determine how many countries have essential asthma medicines on their EML and NRL, which essential asthma medicines, and whether surveys might monitor progress. A cross-sectional survey in 2013–2015 of Global Asthma Network principal investigators generated 111/120 (93%) responses—41 high-income countries and territories (HICs); 70 LMICs. Patients in HICs with NRL are best served (91% HICs included ICS (inhaled corticosteroids) and salbutamol). Patients in the 24 (34%) LMICs with no NRL and the 14 (30%) LMICs with an NRL, however no ICS are likely to have very poor access to affordable, quality-assured ICS. Many LMICs do not have essential asthma medicines on their EML or NRL. Technical guidance and advocacy for policy change is required. Improving access to these medicines will improve the health system’s capacity to address NCDs. MDPI 2019-02-19 2019-02 /pmc/articles/PMC6406388/ /pubmed/30791442 http://dx.doi.org/10.3390/ijerph16040605 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bissell, Karen Ellwood, Philippa Ellwood, Eamon Chiang, Chen-Yuan Marks, Guy B. El Sony, Asma Asher, Innes Billo, Nils Perrin, Christophe Essential Medicines at the National Level: The Global Asthma Network’s Essential Asthma Medicines Survey 2014 |
title | Essential Medicines at the National Level: The Global Asthma Network’s Essential Asthma Medicines Survey 2014 |
title_full | Essential Medicines at the National Level: The Global Asthma Network’s Essential Asthma Medicines Survey 2014 |
title_fullStr | Essential Medicines at the National Level: The Global Asthma Network’s Essential Asthma Medicines Survey 2014 |
title_full_unstemmed | Essential Medicines at the National Level: The Global Asthma Network’s Essential Asthma Medicines Survey 2014 |
title_short | Essential Medicines at the National Level: The Global Asthma Network’s Essential Asthma Medicines Survey 2014 |
title_sort | essential medicines at the national level: the global asthma network’s essential asthma medicines survey 2014 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406388/ https://www.ncbi.nlm.nih.gov/pubmed/30791442 http://dx.doi.org/10.3390/ijerph16040605 |
work_keys_str_mv | AT bissellkaren essentialmedicinesatthenationalleveltheglobalasthmanetworksessentialasthmamedicinessurvey2014 AT ellwoodphilippa essentialmedicinesatthenationalleveltheglobalasthmanetworksessentialasthmamedicinessurvey2014 AT ellwoodeamon essentialmedicinesatthenationalleveltheglobalasthmanetworksessentialasthmamedicinessurvey2014 AT chiangchenyuan essentialmedicinesatthenationalleveltheglobalasthmanetworksessentialasthmamedicinessurvey2014 AT marksguyb essentialmedicinesatthenationalleveltheglobalasthmanetworksessentialasthmamedicinessurvey2014 AT elsonyasma essentialmedicinesatthenationalleveltheglobalasthmanetworksessentialasthmamedicinessurvey2014 AT asherinnes essentialmedicinesatthenationalleveltheglobalasthmanetworksessentialasthmamedicinessurvey2014 AT billonils essentialmedicinesatthenationalleveltheglobalasthmanetworksessentialasthmamedicinessurvey2014 AT perrinchristophe essentialmedicinesatthenationalleveltheglobalasthmanetworksessentialasthmamedicinessurvey2014 AT essentialmedicinesatthenationalleveltheglobalasthmanetworksessentialasthmamedicinessurvey2014 |